1.Identifying COVID-19 confirmed patients at elevated risk for mortality and need of mechanical ventilation using a novel criteria for Hyperinflammatory Syndrome: A retrospective cohort, single-center, validation study.
Jayvee Rho-an D. DESCALSOTA ; Abdul Walli R. CANA ; Inofel I. CHIN ; Jessie F. ORCASITAS
Acta Medica Philippina 2025;59(3):104-115
BACKGROUND AND OBJECTIVES
A mounting evidence links dysregulated immune response to cases of fatal pneumonia seen in COVID-19 infection. We aimed to validate the COVID-19-associated Hyperinflammatory Syndrome (cHIS) score, a novel clinical tool devised to identify those at risk for adverse outcomes, in a local population and investigate the relationship of cHIS score taken at admission and the risk of mortality and the need of mechanical ventilation.
METHODSThis retrospective cohort study analyzed the sociodemographic, clinical, and laboratory data of 1,881 COVID-19 patients admitted at a tertiary hospital in Davao City, Philippines from January to December 2021. We calculated the cHIS score, composed of six clinical and laboratory criteria from admission, and used multivariate logistic regression to determine the risk of mortality and need of mechanical ventilation.
RESULTSThe cHIS score taken at admission, regardless of cut-off value, was a significant predictor of mortality (OR 0.979 [99% CI 0.894-1.064]) and need of mechanical ventilation (OR 0.586 [99% CI 0.4975-0.6745]). Using the Youden Index, a cut-off cHIS score of 3 or more was a better predictor of mortality (sensitivity, 88.59%; specificity, 71.72%), and a cut-off score of 2 or more was a better predictor of need of mechanical ventilation (sensitivity, 84.02%; specificity, 70.82%) than other cutoff cHIS scores.
CONCLUSIONAmong COVID-19 patients, the cHIS score at admission correlated with the risk of mortality and the need of mechanical ventilation. Cutoff scores of 3 and 2 had the optimal sensitivities and specificities to predict the risk of mortality and the need of mechanical ventilation, respectively.
Human ; Covid-19 ; Inflammation ; Mortality ; Mechanical Ventilation ; Respiration, Artificial ; Cytokine Storm ; Cytokine Release Syndrome
3.Development of an Active Mechanical Lung for Simulating Human Pulmonary Ventilation.
Yueyang YUAN ; Lei HU ; Zhongkun XIAO ; Tianle ZHOU ; Feng YAO ; Jiaqi CHEN
Chinese Journal of Medical Instrumentation 2023;47(3):264-267
		                        		
		                        			
		                        			At present, the passive simulated lung including the splint lung is an important device for hospitals and manufacturers in testing the functions of a respirator. However, the human respiration simulated by this passive simulated lung is quite different from the actual respiration. And it is not able to simulate the spontaneous breathing. Therefore, including" the device simulating respiratory muscle work "," the simulated thorax" and" the simulated airway", an active mechanical lung to simulate human pulmonary ventilation was designed:3D printed human respiratory tract was developed and connected the left and right air bags at the end of the respiratory tract to simulate the left and right lungs of the human body. By controlling a motor running to drive the crank and rod to move a piston back and forth, and to deliver an alternating pressure in the simulated pleural, and so as to generate an active respiratory airflow in airway. The experimental respiratory airflow and pressure from the active mechanical lung developed in this study are consistent with the target airflow and pressure which collected from the normal adult. The developed active mechanical lung function will be conducive to improve the quality of the respirator.
		                        		
		                        		
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Lung/physiology*
		                        			;
		                        		
		                        			Respiration
		                        			;
		                        		
		                        			Pulmonary Ventilation
		                        			;
		                        		
		                        			Respiration, Artificial
		                        			;
		                        		
		                        			Ventilators, Mechanical
		                        			
		                        		
		                        	
4.Design and application of decompression fixator to prevent HFNC facial pressure injury.
Chinese Critical Care Medicine 2023;35(7):762-763
		                        		
		                        			
		                        			As a new respiratory support technique, high-flow nasal cannula oxygen therapy (HFNC) has been widely used in clinical practice in recent years. During HFNC treatment, due to the long time and continuous wearing of nasal stopper and fasteners on the patient face, it is easy to cause medical device-related pressure injury on multiple facial skin. Moreover, when the patient's position changes greatly, because there is no good fixed design at the HFNC nasal stopper, it is easy to shift or turn the nasal stopper outward, causing abnormal ventilation and failure to achieve the purpose of clinical oxygen therapy. To overcome above problems, medical staff in the intensive care unit of department of infectious diseases, Tongji Hospital Tongji Medical College of HUST designed a new type of decompression fixator to prevent HFNC face pressure injury, and obtained national utility model patent (ZL 2022 2 0754626.1). The integrated design structure of the device has the functions of decompression of facial skin and fixation of nasal stopper, which can ensure the effect of oxygen therapy and improve the oxygen therapy experience and patient comfort, which is suitable for clinical promotion.
		                        		
		                        		
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Cannula
		                        			;
		                        		
		                        			Pressure Ulcer/prevention & control*
		                        			;
		                        		
		                        			Oxygen Inhalation Therapy/methods*
		                        			;
		                        		
		                        			Oxygen
		                        			;
		                        		
		                        			Decompression
		                        			;
		                        		
		                        			Respiratory Insufficiency/therapy*
		                        			;
		                        		
		                        			Noninvasive Ventilation
		                        			
		                        		
		                        	
5.Efficacy of noninvasive high-frequency oscillatory ventilation versus nasal intermittent positive pressure ventilation as post-extubation respiratory support in preterm infants: a Meta analysis.
Hong-Ke SHI ; Ke-Ling LIANG ; Li-Hua AN ; Bing ZHANG ; Cheng-Yun ZHANG
Chinese Journal of Contemporary Pediatrics 2023;25(3):295-301
		                        		
		                        			OBJECTIVES:
		                        			To systematically evaluate the efficacy and safety of noninvasive high-frequency oscillatory ventilation (NHFOV) versus nasal intermittent positive pressure ventilation (NIPPV) as post-extubation respiratory support in preterm infants.
		                        		
		                        			METHODS:
		                        			China National Knowledge Infrastructure, Wanfang Data, Chinese Journal Full-text Database, China Biology Medicine disc, PubMed, Web of Science, and the Cochrane Library were searched for articles on NHFOV and NIPPV as post-extubation respiratory support in preterm infants published up to August 31, 2022. RevMan 5.4 software and Stata 17.0 software were used for a Meta analysis to compare related indices between the NHFOV and NIPPV groups, including reintubation rate within 72 hours after extubation, partial pressure of carbon dioxide (PCO2) at 6-24 hours after switch to noninvasive assisted ventilation, and the incidence rates of bronchopulmonary dysplasia (BPD), air leak, nasal damage, periventricular leukomalacia (PVL), intraventricular hemorrhage (IVH), and retinopathy of prematurity (ROP).
		                        		
		                        			RESULTS:
		                        			A total of 9 randomized controlled trials were included. The Meta analysis showed that compared with the NIPPV group, the NHFOV group had significantly lower reintubation rate within 72 hours after extubation (RR=0.67, 95%CI: 0.52-0.88, P=0.003) and PCO2 at 6-24 hours after switch to noninvasive assisted ventilation (MD=-4.12, 95%CI: -6.12 to -2.13, P<0.001). There was no significant difference between the two groups in the incidence rates of complications such as BPD, air leak, nasal damage, PVL, IVH, and ROP (P>0.05).
		                        		
		                        			CONCLUSIONS
		                        			Compared with NIPPV, NHFOV can effectively remove CO2 and reduce the risk of reintubation, without increasing the incidence of complications such as BPD, air leak, nasal damage, PVL, and IVH, and therefore, it can be used as a sequential respiratory support mode for preterm infants after extubation.
		                        		
		                        		
		                        		
		                        			Infant
		                        			;
		                        		
		                        			Infant, Newborn
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Infant, Premature
		                        			;
		                        		
		                        			Intermittent Positive-Pressure Ventilation
		                        			;
		                        		
		                        			Airway Extubation
		                        			;
		                        		
		                        			Noninvasive Ventilation
		                        			;
		                        		
		                        			Bronchopulmonary Dysplasia
		                        			;
		                        		
		                        			High-Frequency Ventilation
		                        			;
		                        		
		                        			Respiratory Distress Syndrome, Newborn/therapy*
		                        			;
		                        		
		                        			Continuous Positive Airway Pressure
		                        			
		                        		
		                        	
6.Therapeutic efficacy of volume-guaranteed high frequency oscillation ventilation on respiratory failure in preterm infants with a gestational age of 28-34 weeks: a prospective randomized controlled study.
Lu-Chun WANG ; Zhi-Dan BAO ; Yi-Zhe MA ; Li-Mei NIU ; Ming-Yan TAO
Chinese Journal of Contemporary Pediatrics 2023;25(11):1101-1106
		                        		
		                        			OBJECTIVES:
		                        			To investigate the therapeutic efficacy of volume-guaranteed high frequency oscillation ventilation (HFOV-VG) versus conventional mechanical ventilation (CMV) in the treatment of preterm infants with respiratory failure.
		                        		
		                        			METHODS:
		                        			A prospective study was conducted on 112 preterm infants with respiratory failure (a gestational age of 28-34 weeks) who were admitted to the Department of Neonatology, Jiangyin Hospital Affiliated to Medical School of Southeast University, from October 2018 to December 2022. The infants were randomly divided into an HFOV-VG group (44 infants) and a CMV group (68 infants) using the coin tossing method based on the mode of mechanical ventilation. The therapeutic efficacy was compared between the two groups.
		                        		
		                        			RESULTS:
		                        			After 24 hours of treatment, both the HFOV-VG and CMV groups showed significant improvements in arterial blood pH, partial pressure of oxygen, partial pressure of carbon dioxide, and partial pressure of oxygen/fractional concentration of inspired oxygen ratio (P<0.05), and the HFOV-VG group had better improvements than the CMV group (P<0.05). There were no significant differences between the two groups in the incidence rate of complications, 28-day mortality rate, and length of hospital stay (P>0.05), but the HFOV-VG group had a significantly shorter duration of invasive mechanical ventilation than the CMV group (P<0.05). The follow-up at the corrected age of 6 months showed that there were no significant differences between the two groups in the scores of developmental quotient, gross motor function, fine motor function, adaptive ability, language, and social behavior in the Pediatric Neuropsychological Development Scale (P>0.05).
		                        		
		                        			CONCLUSIONS
		                        			Compared with CMV mode, HFOV-VG mode improves partial pressure of oxygen and promotes carbon dioxide elimination, thereby enhancing oxygenation and shortening the duration of mechanical ventilation in preterm infants with respiratory failure, while it has no significant impact on short-term neurobehavioral development in these infants.
		                        		
		                        		
		                        		
		                        			Infant
		                        			;
		                        		
		                        			Child
		                        			;
		                        		
		                        			Infant, Newborn
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Infant, Premature
		                        			;
		                        		
		                        			Prospective Studies
		                        			;
		                        		
		                        			Gestational Age
		                        			;
		                        		
		                        			Carbon Dioxide
		                        			;
		                        		
		                        			Respiratory Distress Syndrome, Newborn/therapy*
		                        			;
		                        		
		                        			High-Frequency Ventilation/methods*
		                        			;
		                        		
		                        			Respiration, Artificial
		                        			;
		                        		
		                        			Respiratory Insufficiency/therapy*
		                        			;
		                        		
		                        			Oxygen
		                        			;
		                        		
		                        			Cytomegalovirus Infections
		                        			
		                        		
		                        	
7.Neoadjuvant immune checkpoint inhibitor therapy and chemotherapy improve pulmonary ventilation and diffusion function in patients with lung cancer.
Wu'an BAO ; Xia ZHOU ; Feiying GU ; Juan LIN ; Bin LI
Journal of Zhejiang University. Medical sciences 2023;52(5):588-593
		                        		
		                        			OBJECTIVES:
		                        			To investigate changes of pulmonary ventilation function and diffusion function in lung cancer patients after neoadjuvant immune checkpoint inhibitors (ICIs) therapy combined with chemotherapy treatment.
		                        		
		                        			METHODS:
		                        			Patients with newly diagnosed lung cancer (Ⅱa-Ⅲb) admitted to Zhejiang Cancer Hospital from October 2021 to July 2022, who received ICIs combined with chemotherapy for more than two courses were enrolled. Patients underwent pulmonary ventilation function and diffusion function assessments before and after treatment. The demographic information, sizes and locations of cancer lesions, doses and duration of ICIs used, pulmonary function results before and after treatment, and the tumor regression were documented. The changes of pulmonary function parameters before and after the treatment were analyzed with paired t test and Wilcoxon rank-sum test. The factors influencing the pulmonary function changes were analyzed by multiple linear Lasso regression and ridge regression.
		                        		
		                        			RESULTS:
		                        			Among the 52 patients, 50 cases were males (96.15%) and 43 cases were squamous carcinoma (82.69%). The medium age of the patients was 67 years. After neoadjuvant therapy, 36 patients (69.23%) showed remission of tumor lesions. After treatment, the parameters of pulmonary ventilation inspiratory vital capacity (IVC) and the area under the expiratory flow-volume curve (AREAex), and the parameter of pulmonary diffusion total lung capacity increased compared with the baseline (all P<0.05). Forced vital capacity (FVC) and forced expiratory volume in first second (FEV1) also showed an increasing trend. Multivariate linear Lasso regression and ridge regression showed that baseline IVC had a significant negative effect on IVC improvement (Beta=-0.435, t=-2.968, P<0.01), baseline TLC had a significant negative effect on the improvement of TLC (Beta=-0.266, t=-2.474, P<0.05), and the remission of obstructive pneumonia favored the improvement of TLC (Beta=0.308, t=2.443, P<0.05).
		                        		
		                        			CONCLUSIONS
		                        			After ICIs neoadjuvant treatment combined with chemotherapy, the lung ventilation and diffusion function can be improved in lung cancer patients, particularly for those with reduced baseline ventilation and diffusion function.
		                        		
		                        		
		                        		
		                        			Male
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Lung Neoplasms/drug therapy*
		                        			;
		                        		
		                        			Neoadjuvant Therapy
		                        			;
		                        		
		                        			Immune Checkpoint Inhibitors/pharmacology*
		                        			;
		                        		
		                        			Lung
		                        			;
		                        		
		                        			Pulmonary Ventilation
		                        			
		                        		
		                        	
8.Interpretation of new concepts and approaches in the ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies.
Zemeng LI ; Yanhai MENG ; Lulu LI ; Yanbo ZHANG
Chinese Critical Care Medicine 2023;35(9):919-926
		                        		
		                        			
		                        			Acute respiratory distress syndrome (ARDS) continues to be one of the most life-threatening conditions for patients in the intensive care unit (ICU). The 2023 European Society of Intensive Care Medicine guidelines on ARDS: definition, phenotyping and respiratory support strategies (2023 Guideline) update the 2017 An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine clinical practice guideline: mechanical ventilation in adult patients with ARDS (2017 Guideline), including 7 aspects of 3 topics of definitions, phenotyping, and respiratory support strategies [including high flow nasal cannula oxygen (HFNO), non-invasive ventilation (NIV), neuromuscular blocking agents (NMBA), extracorporeal life support (ECLS), positive end-expiratory pressure (PEEP) with recruitment maneuvers (RM), tidal volume (VT), and prone positioning]. 2023 Guideline review and summarize the literature since the publication of the 2017 Guideline, covering ARDS and acute hypoxemic respiratory failure, as well as ARDS caused by novel coronavirus infection. Based on the most recent medical evidence, the 2023 Guideline provide clinicians with new ideas and approaches for nonpharmacologic respiratory support strategies for adults with ARDS. This article provides interpretation of the new concepts, the new approaches, the new recommended grading and new levels of evidence for ARDS in the 2023 Guideline.
		                        		
		                        		
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			COVID-19
		                        			;
		                        		
		                        			Respiration, Artificial
		                        			;
		                        		
		                        			Positive-Pressure Respiration
		                        			;
		                        		
		                        			Respiratory Distress Syndrome/therapy*
		                        			;
		                        		
		                        			Noninvasive Ventilation
		                        			
		                        		
		                        	
9.Numerical simulation modeling of middle ear-eustachian tube ventilation based on Chinese digital visual human body.
Xiao Hui ZHU ; Qi TANG ; Meng Yao XIE ; Ruo Yan XUE ; Yong Li ZHANG ; Yi WU ; Xin HU ; Hua YANG ; Zhi Qiang GAO
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2022;57(4):452-457
		                        		
		                        			
		                        			Objective: To establish a three-dimensional model of middle ear-eustachian tube based on Chinese digital visual human dataset, and the deformation and pressure changes of the middle ear-eustachian tube system after eustachian tube opening are simulated by computer numerical simulation. Methods: The first female Chinese Digital Visual Human data was adopted. The images were imported by Amira image processing software, and the images were segmented by Geomagic software to form a three-dimensional model of middle ear-eustachian tube system, including eustachian tube, tympanum, tympanic membrane, auditory ossicles, and mastoid air cells system. The 3D model was imported into Hypermesh software for meshing and analysis. The structural mechanics calculation was carried out by Abaqus, and gas flow was simulated by Xflow. The tissue deformation and middle ear pressure changes during eustachian tube opening were numerically simulated by fluid-solid coupling algorithm. Several pressure monitoring points including tympanum, mastoid, tympanic isthmus, and external auditory canal were set up in the model, and the pressure changes of each monitoring point were recorded and compared. Results: In this study, a three-dimensional model of middle ear-eustachian tube and a numerical simulation model of middle ear ventilation were established, including eustachian tube, tympanum, mastoid air cells, tympanic membrane, and auditory ossicles. The dynamic changes of the model after ventilation could be divided into five stages according to the pressure. In addition, the pressure changes of tympanum and tympanic isthmus were basically synchronous, and the pressure changes of mastoid air cells system were later than that of tympanum and tympanic isthmus, which verified the pressure buffering effect of mastoid. The extracted pressure curve of the external auditory canal was basically consistent with that of tympanometry in terms of value and trend, which verified the effectiveness of the model. Conclusions: The numerical simulation model of middle ear-eustachian tube ventilation established in this paper can simulate the tissue deformation and middle ear pressure changes after eustachian tube opening, and its accuracy and effectiveness are also verified. This not only lays a foundation for further research, but also provides a new research method for the study of middle ear ventilation.
		                        		
		                        		
		                        		
		                        			China
		                        			;
		                        		
		                        			Ear, Middle
		                        			;
		                        		
		                        			Eustachian Tube
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Human Body
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Middle Ear Ventilation
		                        			
		                        		
		                        	
10.Otologic disorders and management strategies in Turner syndrome.
Yu SI ; Ying XIONG ; Li Na ZHANG ; Xiang Hui LI ; Shi Pei ZHUO ; Yi Si FENG ; Li Yang LIANG ; Zhi Gang ZHANG
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2022;57(5):595-601
		                        		
		                        			
		                        			Objective: To analyze the incidence and risk factors of otologic disorders in patients with Turner syndrome (TS), so as to provide management strategies for ear health. Methods: This study is a prospective study based on questionnaires and a cross-sectional study. The TS patients who visited our hospital from 2010 January to 2021 March were included (A total of 71 patients with TS were included in this study. the age of TS diagnosed was 3- to 11-year-old, age of visiting ENT department was 4- to 27-year-old) and the incidence of otologic diseases in different age groups was investigated by questionnaires. The cross-sectional study included ear morphology and auditory function assessment, and further analysis of the risk factors that related to ear disease. Prism was used for data analysis. Results: The investigation found that the incidence of acute otitis media in patients aged 3-6 and 7-12 years was higher than that of patients over 12 years old, which was 33.8%(24/71), 42.9%(30/70)and 23.5%(8/34), respectively; 21.1% (15/71) of patients were recurrent acute otitis media in patients aged 3-6 years, and about 46.6% (7/15)of them persisted beyond 6-year. The prevalence of otitis media with effusion in the three groups was 32.4%(23/71), 34.3%(24/70)and 38.2%(13/34), respectively; the recurrence rate of tympanocentesis was 100%(7/7), 42.9%(3/7)and 50.0%(1/2), which was significantly higher than that of grommet insertion. For age groups of 3-6 and 7-12 years, the prevalence of acute otitis media and secretory otitis media was lower in the X chromosome structure abnormal patients; while for patients older than 12 years, otitis media with effusion was the highest prevalence in Y-chromosome-containing karyotypes. In addition, the prevalence of acute otitis media and otitis media with effusion in patients with other system diseases were increased significantly. A cross-sectional study found that 7.0% (5/71)of the lower auricular, 4.2% (3/71)of the external auditory canal narrow, and 38.0% (27/71)of the tympanic membrane abnormality. 35.2%(25/71) had abnormal hearing, including 17 cases of conductive deafness, 6 cases of sensorineural hearing loss, and 2 cases of mixed deafness. The rest of the patients had normal hearing, but 6 of them had abnormalities in otoacoustic emission. Eustachian tube function assessment found that the eustachian tube dysfunction accounted for 38%(27/71). Hearing loss and abnormal Eustachian tube function were not significantly related to karyotype(Chi-square 2.83 and 2.84,P value 0.418 and 0.417), but significantly related to other system diseases(Chi-square 13.43 and 7.53,P value<0.001). Conclusions: The incidence of TS-related otitis media and auditory dysfunction is significantly higher than that of the general population. It not only occurs in preschool girls, but also persists or develops after school age. Accompanied by other system diseases are risk factors for ear diseases. Clinicians should raise their awareness of TS-related ear diseases and incorporate ear health monitoring into routine diagnosis and treatment.
		                        		
		                        		
		                        		
		                        			Adolescent
		                        			;
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Child
		                        			;
		                        		
		                        			Child, Preschool
		                        			;
		                        		
		                        			Cross-Sectional Studies
		                        			;
		                        		
		                        			Deafness/etiology*
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Middle Ear Ventilation/adverse effects*
		                        			;
		                        		
		                        			Otitis Media/complications*
		                        			;
		                        		
		                        			Otitis Media with Effusion/complications*
		                        			;
		                        		
		                        			Prospective Studies
		                        			;
		                        		
		                        			Turner Syndrome/therapy*
		                        			;
		                        		
		                        			Young Adult
		                        			
		                        		
		                        	
            

Result Analysis
Print
Save
E-mail